ARQQ three-lens brief
Evidence-based stock research on ARQQ. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Underperforming SPY by 34.8pp over 30 days. · Trading >3% below the 50-day MA — short-term weakness.
- Trading >3% below the 50-day MA — short-term weakness.
- Underperforming SPY by 34.8pp over 30 days.
- P/E of 1.4 — trading at a value multiple.
- Earnings scheduled 2026-12-08.
ARQQ closed at $15.59 (-0.95%) as of 2026-11-12. Market cap: $271.30M. P/E (trailing) 1.4. Price is below the 50-day MA and below the 200-day MA. Positives: p/E of 1.4 — trading at a value multiple.. Concerns: trading >3% below the 50-day MA — short-term weakness.; underperforming SPY by 34.8pp over 30 days.. Watching for: 2026-12-08 earnings release (26 days out).
Why three lenses on ARQQ, not one.
A single reasoning model has blind spots it doesn’t know about. We examine ARQQ across Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://www.clearpathinvest.app/embed/ARQQ" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath ARQQ brief"></iframe>